ZATZ STEVEN L

SEC source: 0001470831-26-000906 · wk-form4_1790629367.xml · nonDerivative · entry 2

ZATZ STEVEN L · CIK 0001230589 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,291

F2 · shares: These shares represent RSUs granted on September 24, 2026, which vest in equal quarterly installments over 12 months beginning on May 15, 2027, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001470831-26-000906 · wk-form4_1790629367.xml · nonDerivative · entry 1

ZATZ STEVEN L · CIK 0001230589 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,791

F1 · shares: These shares represent restricted stock units (each, an "RSU") granted on September 24, 2026, which vest as to 50% on each of November 15, 2026 and February 15, 2027, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001470831-26-000825 · wk-form4_1787006528.xml · nonDerivative · entry 1

ZATZ STEVEN L · CIK 0001230589 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,864

F1 · shares: Represents shares of Class A Common Stock withheld by the Issuer in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. Such withholding is mandated by an election of the Issuer made in advance and does not represent a discretionary trade by the Reporting Person.

SEC source: 0001230589-26-000004 · wk-form4_1784938772.xml · derivative · entry 1

ZATZ STEVEN L · CIK 0001230589 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Class A Common Stock · 150,000 shares

Expires 2036-07-22

F1 · derivative.exercise_date: The stock option vests in three equal annual installments beginning on July 22, 2027, subject to Dr. Zatz's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on July 22, 2026.

SEC source: 0001470831-26-000556 · wk-form4_1781814535.xml · nonDerivative · entry 1

ZATZ STEVEN L · CIK 0001230589 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,346

F1 · shares: These shares represent restricted stock units (each, an "RSU") granted on May 15, 2026, which vest in equal quarterly installments over 12 months beginning on August 15, 2026, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0000947871-17-000727 · ss59056_4.xml · derivative · entry 9

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 150,000 shares

Expires 2026-11-02

F4 · security: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F5 · shares: All of the shares underlying the options expiring on July 23, 2021, November 14, 2022 and August 11, 2023 are vested. For the options expiring on March 25, 2025, 40,000 underlying shares are unvested. For the options expiring on November 2, 2026, all underlying shares are unvested.

F4 · price: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

SEC source: 0000947871-17-000727 · ss59056_4.xml · derivative · entry 8

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires 2025-03-25

F4 · security: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F5 · shares: All of the shares underlying the options expiring on July 23, 2021, November 14, 2022 and August 11, 2023 are vested. For the options expiring on March 25, 2025, 40,000 underlying shares are unvested. For the options expiring on November 2, 2026, all underlying shares are unvested.

F4 · price: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

SEC source: 0000947871-17-000727 · ss59056_4.xml · derivative · entry 7

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 300,000 shares

Expires 2023-08-11

F4 · security: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F5 · shares: All of the shares underlying the options expiring on July 23, 2021, November 14, 2022 and August 11, 2023 are vested. For the options expiring on March 25, 2025, 40,000 underlying shares are unvested. For the options expiring on November 2, 2026, all underlying shares are unvested.

F4 · price: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

SEC source: 0000947871-17-000727 · ss59056_4.xml · derivative · entry 6

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2022-11-14

F4 · security: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F5 · shares: All of the shares underlying the options expiring on July 23, 2021, November 14, 2022 and August 11, 2023 are vested. For the options expiring on March 25, 2025, 40,000 underlying shares are unvested. For the options expiring on November 2, 2026, all underlying shares are unvested.

F4 · price: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

SEC source: 0000947871-17-000727 · ss59056_4.xml · derivative · entry 5

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75,000 shares

Expires 2021-07-23

F4 · security: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F5 · shares: All of the shares underlying the options expiring on July 23, 2021, November 14, 2022 and August 11, 2023 are vested. For the options expiring on March 25, 2025, 40,000 underlying shares are unvested. For the options expiring on November 2, 2026, all underlying shares are unvested.

F4 · price: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to the completion of the Merger, or that vested upon the completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option. Each unvested option was converted into the right of the holder to receive an amount in cash equal to the excess of $66.50 over the applicable exercise price of each such option, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such option (or earlier if subject to acceleration in accordance with its terms).

SEC source: 0000947871-17-000727 · ss59056_4.xml · nonDerivative · entry 4

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 0

F1 · shares: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement")

SEC source: 0000947871-17-000727 · ss59056_4.xml · nonDerivative · entry 3

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · shares: Pursuant to the Merger Agreement, each performance share that was outstanding and unvested immediately prior to the completion of the Merger was converted (assuming achievement of maximum level of performance criteria) into the right of the holder to receive an amount in cash equal to $66.50, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such performance share (or earlier if subject to acceleration in accordance with its terms).

SEC source: 0000947871-17-000727 · ss59056_4.xml · nonDerivative · entry 2

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

F2 · shares: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each restricted share that was outstanding and unvested immediately prior to the completion of the Merger was converted into the right of the holder to receive an amount in cash equal to $66.50, which will, subject to its terms and conditions, be scheduled to be payable promptly following the applicable vesting date for such restricted share (or earlier if subject to acceleration in accordance with its terms).

SEC source: 0000947871-17-000727 · ss59056_4.xml · nonDerivative · entry 1

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

F1 · shares: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement")

SEC source: 0000947871-17-000643 · ss55255_4.xml · nonDerivative · entry 1

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,514

F1 · shares: Represents shares that were withheld by WebMD Health Corp. to cover tax withholding arising from a vesting of restricted stock.

SEC source: 0000947871-17-000251 · ss36507_4.xml · nonDerivative · entry 1

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,492

F1 · shares: Represents shares that were withheld by WebMD Health Corp. to cover tax withholding arising from a vesting of restricted stock.

SEC source: 0000947871-16-001629 · ss17852_4.xml · derivative · entry 4

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2026-11-02

F3 · kind: Award of options that will vest in equal annual installments over the second, third and fourth anniversary of the grant date.

F3 · derivative.exercise_date: Award of options that will vest in equal annual installments over the second, third and fourth anniversary of the grant date.

SEC source: 0000947871-16-001629 · ss17852_4.xml · nonDerivative · entry 3

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,656

F2 · kind: Shares of Issuer's common stock subject to a grant of restricted stock that will vest December 31, 2019, subject to satisfaction of certain performance criteria and certain exceptions set forth in the applicable award agreement.

F2 · price: Shares of Issuer's common stock subject to a grant of restricted stock that will vest December 31, 2019, subject to satisfaction of certain performance criteria and certain exceptions set forth in the applicable award agreement.

SEC source: 0000947871-16-001629 · ss17852_4.xml · nonDerivative · entry 2

ZATZ STEVEN L · CIK 0001230589 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,656

F1 · kind: Shares of Issuer's common stock subject to a grant of restricted stock that will vest in equal annual installments over the second, third and fourth anniversary of the grant date.

F1 · price: Shares of Issuer's common stock subject to a grant of restricted stock that will vest in equal annual installments over the second, third and fourth anniversary of the grant date.